U.S. Markets close in 3 hrs 45 mins

Kura Oncology, Inc. (KURA)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
13.10-0.33 (-2.46%)
As of 12:15PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close13.43
Bid13.01 x 1300
Ask13.03 x 900
Day's Range12.97 - 14.00
52 Week Range10.41 - 19.93
Avg. Volume844,525
Market Cap871.881M
Beta (5Y Monthly)1.07
PE Ratio (TTM)N/A
EPS (TTM)-1.69
Earnings DateNov 02, 2022 - Nov 07, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est35.44
  • GlobeNewswire

    Kura Oncology to Participate in H.C. Wainwright Global Investment Conference

    SAN DIEGO, Sept. 01, 2022 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced that Troy Wilson, Ph.D., J.D., President and Chief Executive Officer, is scheduled to participate in the H.C. Wainwright 24th Annual Global Investment Conference. A pre-recorded presentation will be available to view on-demand beginning at 7:00 a.m. ET / 4:00 a.m. PT on S

  • Insider Monkey

    10 Small-Cap Growth Stocks Hedge Funds Love

    In this article we present the list of 10 Small-Cap Growth Stocks Hedge Funds Love. Click to skip ahead and see the 5 Small-Cap Growth Stocks Hedge Funds Love. Madison Square Garden Sports Corp. (NYSE:MSGS), Boyd Gaming Corporation (NYSE:BYD), and Chegg, Inc. (NYSE:CHGG) are a few of the small-cap growth stocks that the hedge fund industry […]

  • Investor's Business Daily

    Kura Oncology Stock Joins Rank Of Stocks With RS Ratings Over 90

    Kura Oncology shows improving price performance, earning an upgrade to its IBD Relative Strength Rating.